3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Osteoporosis
6
Breast Neoplasms
5
Prostatic Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Cardiovascular Diseases
2
Bone Diseases, Metabolic
2
Stomach Neoplasms
1
Psychological Well-Being
1
Pain
1
Neoplasms
1
Myocardial Ischemia
1
Multiple Myeloma
1
Motor Activity
1
Melanoma, Cutaneous Malignant
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Heart Diseases
1
Fractures, Bone
1
Esophageal Neoplasms
1
Disease Progression
1
Coronary Disease
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Bone Diseases
1
Interventions
Paclitaxel
20
Gemcitabine
16
Dexamethasone
16
Bevacizumab
16
Docetaxel
15
Oxaliplatin
14
Cyclophosphamide
13
Carboplatin
12
Capecitabine
12
Sorafenib
11
Fluorouracil
11
Leucovorin
10
Cisplatin
10
pembrolizumab
9
Prednisone
9
Pemetrexed
9
Epoetin Alfa
9
venetoclax
8
atezolizumab
8
Fentanyl
8
Drug Therapy
8
Doxorubicin
8
Rivaroxaban
7
Rituximab
7
Darbepoetin alfa
7
Anastrozole
7
Panitumumab
6
Ondansetron
6
Morphine
6
Irinotecan
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms
×
Vitamin D
×
Clear all
NCT01646437
2021-09-16
TIPS-3
Population Health Research Institute
Phase 3
Completed
7,793 enrolled